Analyst Activity – HC Wainwright Raises Its Price Target On Paratek Pharmaceuticals (NASDAQ:PRTK) to $43.00

ME Staff
-
0

Analyst Ratings For Paratek Pharmaceuticals (NASDAQ:PRTK)

Today, HC Wainwright raised its price target on Paratek Pharmaceuticals (NASDAQ:PRTK) to $43.00 per share.

There are 7 buy ratings, 1 strong buy rating on the stock.

The current consensus rating on Paratek Pharmaceuticals (NASDAQ:PRTK) is Buy (Score: 3.13) with a consensus target price of $39.50 per share, a potential 58.32% upside.

Some recent analyst ratings include

  • 5/18/2017-Raymond James Financial, Inc. initiated coverage with a Strong-Buy rating.
  • 4/4/2017-Robert W. Baird Reiterated Rating of Outperform.
  • 4/3/2017-Wedbush Reiterated Rating of Outperform .

Recent Insider Trading Activity For Paratek Pharmaceuticals (NASDAQ:PRTK)
Paratek Pharmaceuticals (NASDAQ:PRTK) has insider ownership of 4.90% and institutional ownership of 75.58%.

  • On 7/5/2017 Adam Woodrow, VP, sold 3,800 with an average share price of $23.58 per share and the total transaction amounting to $89,604.00. View SEC Filing
  • On 7/5/2017 Douglas W Pagan, CFO, sold 4,139 with an average share price of $23.58 per share and the total transaction amounting to $97,597.62. View SEC Filing
  • On 7/5/2017 Evan Loh, COO, sold 4,351 with an average share price of $23.58 per share and the total transaction amounting to $102,596.58. View SEC Filing
  • On 7/5/2017 Michael Bigham, Chairman, sold 5,075 with an average share price of $23.58 per share and the total transaction amounting to $119,668.50. View SEC Filing
  • On 6/19/2017 Douglas W Pagan, CFO, sold 4,595 with an average share price of $25.00 per share and the total transaction amounting to $114,875.00. View SEC Filing
  • On 2/6/2017 Douglas W Pagan, CFO, sold 3,405 with an average share price of $15.09 per share and the total transaction amounting to $51,381.45. View SEC Filing
  • On 2/6/2017 Evan Loh, COO, sold 3,106 with an average share price of $15.09 per share and the total transaction amounting to $46,869.54. View SEC Filing

Recent Trading Activity for Paratek Pharmaceuticals (NASDAQ:PRTK)
Shares of Paratek Pharmaceuticals closed the previous trading session at 24.50 down -0.45 -1.80% with 1,487,709 shares trading hands.